156 related articles for article (PubMed ID: 31182739)
1. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.
Zhang Y; Wang SS; Tao L; Pang LJ; Zou H; Liang WH; Liu Z; Guo SL; Jiang JF; Zhang WJ; Jia W; Li F
Sci Rep; 2019 Jun; 9(1):8401. PubMed ID: 31182739
[TBL] [Abstract][Full Text] [Related]
2. MAP3K3 overexpression is associated with poor survival in ovarian carcinoma.
Jia W; Dong Y; Tao L; Pang L; Ren Y; Liang W; Jiang J; Cheng G; Zhang WJ; Yuan X; Li F
Hum Pathol; 2016 Apr; 50():162-9. PubMed ID: 26997451
[TBL] [Abstract][Full Text] [Related]
3. CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3.
Li B; Zhang L
J Ovarian Res; 2021 Nov; 14(1):160. PubMed ID: 34789310
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
5. DNM3OS Facilitates Ovarian Cancer Progression by Regulating miR-193a-3p/MAP3K3 Axis.
He L; He G
Yonsei Med J; 2021 Jun; 62(6):535-544. PubMed ID: 34027641
[TBL] [Abstract][Full Text] [Related]
6. MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.
He Y; Wang L; Liu W; Zhong J; Bai S; Wang Z; Thomas DG; Lin J; Reddy RM; Ramnath N; Carrott PW; Lynch WR; Orringer MB; Chang AC; Beer DG; Chen G
Sci Rep; 2015 Jun; 5():11471. PubMed ID: 26088427
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.
Li MM; Dong CX; Sun B; Lei HZ; Wang YL; Gong YB; Sun LL; Sun ZW
Life Sci; 2019 Dec; 239():116946. PubMed ID: 31610202
[TBL] [Abstract][Full Text] [Related]
8. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
Tang H; Lv W; Sun W; Bi Q; Hao Y
Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
[TBL] [Abstract][Full Text] [Related]
9. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
[TBL] [Abstract][Full Text] [Related]
11. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
[TBL] [Abstract][Full Text] [Related]
12. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
13. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
14. MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression.
Yin W; Shi L; Mao Y
FEBS Open Bio; 2019 Jan; 9(1):43-52. PubMed ID: 30652073
[TBL] [Abstract][Full Text] [Related]
15. RPS15A promotes gastric cancer progression via activation of the Akt/IKK-β/NF-κB signalling pathway.
Liu C; He X; Liu X; Yu J; Zhang M; Yu F; Wang Y
J Cell Mol Med; 2019 Mar; 23(3):2207-2218. PubMed ID: 30661291
[TBL] [Abstract][Full Text] [Related]
16. Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.
Fan Y; Ge N; Wang X; Sun W; Mao R; Bu W; Creighton CJ; Zheng P; Vasudevan S; An L; Yang J; Zhao YJ; Zhang H; Li XN; Rao PH; Leung E; Lu YJ; Gray JW; Schiff R; Hilsenbeck SG; Osborne CK; Yang J; Zhang H
J Pathol; 2014 Jan; 232(1):75-86. PubMed ID: 24122835
[TBL] [Abstract][Full Text] [Related]
17. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract][Full Text] [Related]
18. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
19. Expression of Dual-Specificity Phosphatase 2 (DUSP2) in Patients with Serous Ovarian Carcinoma and in SKOV3 and OVCAR3 Cells In Vitro.
Liu W; Tian X; Ding X; Zhang L
Med Sci Monit; 2019 Dec; 25():10180-10189. PubMed ID: 31889045
[TBL] [Abstract][Full Text] [Related]
20. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]